BT
BTB Therapeutics, Inc.
SEC filingPharmaceuticals · Escondido, CA
Amount raised$8.9Msold at filing
Total offering$10.4M$1.5M still open
Investors in the raise4count reported to the SEC
FiledAug 12, 2026first sale Nov 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Takashi KiyoizumiExecutive Officer, Director
Masatoshi HagiwaraDirector
David SnyderDirector
Nobuhiro YagiDirector
Sidney YeeDirector
Executive officers, directors and promoters as listed on the Form D.